DexCom Inc (DXCM)

Exchange
NASDAQ
Symbol
DXCM
Sector
Life Sciences
Industry
Surgical & Medical Instruments & Apparatus
Description
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    69.82
  • High
    70.25
  • Low
    67.90
  • Close
    68.61
  • Volume
    5,193,570

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
4.53
Receivables turnover
3.65
Payables turnover
9.17
Working capital turnover
1.26
Days of inventory on hand (DOH)
80.62
Days of sales outstanding (DSO)
100.03
Number of days of payables
39.82
Fixed asset turnover
3.24
Total asset turnover
0.58
 Liquidity ratios
Current ratio
2.84
Quick ratio
2.39
Cash ratio
1.75
Cash conversion cycle
140.83
 Solvency ratios
Debt-to-assets ratio
0.39
Debt-to-capital ratio
0.54
Debt-to-equity ratio
1.18
Financial leverage ratio
3.03
Interest coverage
36.00
 Profitability ratios
Gross profit margin
63.52%
Operating profit margin
16.59%
Pretax margin
19.72%
Net profit margin
15.03%
Operating return on assets (Operating ROA)
9.54%
Return on assets (ROA)
8.64%
Return on total capital
16.23%
Return on equity (ROE)
26.18%